The TGA advises that GNY Australia has initiated a recall of GNY Slimming Pills - labelled as MSV (Strong Version), ESV (Extra Strong Version) and GRL (Rapid Loss Soft Gel Capsules) - as they pose a serious health risk.
Testing by the TGA has found that these products contain sibutramine, a prescription-only ingredient that has not been declared on the product labels.
Sibutramine was the active ingredient in Reductil, which was withdrawn from the Australian market in October 2010 because a major study revealed that it caused an increased risk of cardiovascular events.
GNY Slimming Pills should not be taken as they may be harmful and can cause symptoms including headaches, dizziness and dry mouth.
GNY Slimming Pills, labelled as MSV, ESV and GRL, have been illegally supplied in Australia, as they are not listed on the Australian Register of Therapeutic Goods (ARTG) and, as such, have not been assessed by the TGA for quality, safety or efficacy, as required under Australian law. Also, the place of manufacture is not approved by the TGA.
Information for consumers
If you have any GNY Slimming Pills, labelled as MSV, ESV and GRL:
- stop taking it
- contact GNY Australia's customer service line on 0431 123 901 to arrange return of the affected product.
If you have any questions or concerns arising from your use of GNY Slimming Pills, contact your health professional.
The TGA advises consumers to exercise extreme caution when purchasing medicines from unknown overseas internet sites.
Products purchased online:
- may contain undisclosed and potentially harmful ingredients
- may not meet the same standards of quality, safety and efficacy as those approved by the TGA for supply in Australia.
Reporting problems
Consumers and health professionals are encouraged to report problems with medicines or vaccines. Your report will contribute to the TGA's monitoring of these products.
The TGA cannot give advice about an individual's medical condition. You are strongly encouraged to talk with a health professional if you are concerned about a possible adverse event associated with a medicine or vaccine.